when was tirzepatide fda approved approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price FDA approves new obesity drug

Light activity is fine

Working with a physician or dietitian can help ensure patients meet healthy intake and hydration goals

These are experimental patterns

Sermorelin tends to have fewer systemic side effects than exogenous GH, but localized and hormonal reactions can still occur in sensitive individuals. Merriam et al., Clinical Endocrinology Common Side Effects Injection site irritation (redness, swelling, or discomfort) Headaches and dizziness Temporary water retention or puffiness Nausea or lightheadedness shortly after dosing Flu-like symptoms (rare, typically early in treatment) Less Common But Notable Risks Carpal tunnel symptoms (numbness/tingling in hands) Mood changes or mild anxiety due to elevated cortisol Gynecomastia (in rare cases with high GH/IGF-1 over time) Insulin sensitivity changes with prolonged or stacked use Mitigation Tips Start with lower doses and titrate slowly Rotate injection sites to prevent irritation Avoid late-night meals high in carbs or fat , which can blunt GH spikes Consider cycling off after 812 weeks to restore baseline sensitivity If youre stacking Sermorelin with other peptides like Ipamorelin or MK-677 , be mindful of synergistic effects on appetite, cortisol, or water retention